SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000912057-00-054698
Filing Date
2000-12-26
Accepted
2000-12-26 00:00:00
Documents
4

Document Format Files

Seq Description Document Type Size
1 S-3 a2033996zs-3.txt S-3 83798
2 EXHIBIT 5.1 a2033996zex-5_1.txt EX-5.1 2589
3 EXHIBIT 23.1 a2033996zex-23_1.txt EX-23.1 675
4 EXHIBIT 99.2 a2033996zex-99_2.txt EX-99.2 51278
  Complete submission text file 0000912057-00-054698.txt   140178
Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-52736 | Film No.: 795540
SIC: 2835 In Vitro & In Vivo Diagnostic Substances